Pissing Match Over Kidney Treatment--Did Marketing Concerns Trump Good Medicine?

The Washington Post documents how three senior scientists at a medical journal (world's largest and oldest renal care journal) approved an editorial that took a strong unfavorable position regarding prescribing an expensive drug for kidney dialysis patients. Then the journal's marketing department, not the scientists, pulled the editorial so they would not lose any advertising money from the drug company. You should be very concerned about the pervasive influence of the pharmaceutical...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports